Postprandial Response of Individuals to Dietary Inorganic Phosphate
NCT03771924 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2020-05-19
Summary
The study aims to compare the postprandial response of plasma phosphate and cardiometabolic relevant factors to phosphate intake in defined diet(s).
Conditions
- Cardiovascular Risk Factor
Interventions
- DIETARY_SUPPLEMENT
-
inorganic phosphate
Sodium phosphate
- DIETARY_SUPPLEMENT
-
placebo
Sodium chlorid
Sponsors & Collaborators
-
German Federal Ministry of Education and Research
collaborator OTHER_GOV -
Martin-Luther-Universität Halle-Wittenberg
lead OTHER
Principal Investigators
-
Gabriele Stangl, Prof.Dr. · MLU, Institut für Agrar-und Ernährungswissenschaften
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-16
- Primary Completion
- 2018-11-25
- Completion
- 2020-01-20
Countries
- Germany
Study Locations
More Related Trials
-
Impact of Levagen+® Palmitoylethanolamide (PEA) in a Cross-Over Trial Examining Stress and Cognition in University Students
NCT06225440 ·Status: COMPLETED ·Phase: NA
-
A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804
NCT01479647 ·Status: COMPLETED ·Phase: PHASE1
-
Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects
NCT03448172 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED)
NCT00874120 ·Status: COMPLETED ·Phase: PHASE3
-
Food Effect Study for PF-06372865
NCT02217787 ·Status: COMPLETED ·Phase: PHASE1
-
Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429
NCT01117233 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers
NCT00797342 ·Status: COMPLETED ·Phase: PHASE1
-
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
NCT02151617 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants
NCT03381144 ·Status: TERMINATED ·Phase: PHASE1
-
Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects
NCT01794364 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants
NCT04323124 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated
NCT01165723 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions
NCT02184429 ·Status: COMPLETED ·Phase: PHASE1
-
A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets
NCT03445169 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Following A Single Dose Of PF-04995274 In Healthy Adult Volunteers
NCT01091272 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects
NCT04919551 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants
NCT00886093 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy Adults
NCT05349864 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of Multiple Doses of PF-06305591
NCT01776619 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Food Effect on Pharmacokinetics of HMPL-523 Acetate Tablets
NCT07348133 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects
NCT03217604 ·Status: COMPLETED ·Phase: PHASE1
-
A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865
NCT01951144 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects
NCT04297865 ·Status: UNKNOWN ·Phase: PHASE1
-
Influence of Plantago Major on Mineral Metabolism and Selected Biochemical Parameters in Obese Women
NCT03439540 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.
NCT01451775 ·Status: COMPLETED ·Phase: PHASE1